Status:
COMPLETED
Self Reported Deviations From Opioid Analgesic Prescription
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Advanced Cancers
Eligibility:
All Genders
18+ years
Brief Summary
Primary Objective: 1. To determine the frequency of self-reported over and under use of opioid analgesics in patients with advanced cancer. Patients with advanced cancer are those patients who have b...
Detailed Description
Screening: Before you start the study, the research nurse will check your medical record to see if you are eligible to take part in this study. Information will be recorded about your demographics (s...
Eligibility Criteria
Inclusion
- Patients must be at least 18 years old and have a diagnosis of advanced cancer.
- Patients must be given prescriptions for around the clock (ATC) and as needed (for breakthrough pain) oral opioids for cancer pain on the previous visit to the Palliative Care Clinic.
- Patients must be able to understand, read, write, and speak English.
- Patients must have no clinical evidence of cognitive impairment, as determined by the primary palliative care physician.
- Patients must sign an informed consent.
Exclusion
- Patients who have the caregiver as the primary person that does the management of opioid medication intake will be excluded as analysis is focused on patients' and not the family or caregivers' knowledge, attitudes and beliefs as it relates to the primary objective.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00907192
Start Date
May 1 2009
End Date
June 1 2012
Last Update
June 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030